GLOW peptide is a blend of three research peptides: GHK-Cu, BPC-157 and TB-500 [1]. It is usually discussed in connection with skin, and that link comes mostly from one ingredient, GHK-Cu. Each peptide has been studied on its own, but there is no published research on the GLOW blend as a whole.
Here is what is in GLOW peptides, what the research on each ingredient shows, and where the evidence runs out.
Key takeaways
- GLOW combines GHK-Cu, BPC-157 and TB-500 in one blend.
- GHK-Cu is the only ingredient with human skin studies, and those used creams, not injections.
- BPC-157 and TB-500 research comes mostly from animals and lab work.
- KLOW is GLOW with one extra peptide, KPV.
What Is GLOW Peptide?
GLOW is a trade-style name, not a scientific one. You will also see it written as the glow stack, glow blend or “glo peptide,” but these all point to the same three ingredients.
- Glow blend: the three peptides are mixed and supplied in one vial.
- Glow stack: the three are kept separate but grouped together.
Two of the three, BPC-157 and TB-500, already have a name as a pair: the wolverine stack. GLOW adds GHK-Cu to that pair.
What Is in GLOW Peptide?
A peptide is a short chain of amino acids, the building blocks of proteins. GLOW contains three of them:
| Ingredient | What it is, in plain words | Main research area | Type of evidence |
|---|---|---|---|
| GHK-Cu | A 3-amino-acid peptide bound to copper, found naturally in human blood | Skin, collagen, wound healing | Cell, animal and human skin-cream studies |
| BPC-157 | A 15-amino-acid peptide first found in stomach juice | Muscle, tendon and other tissue repair | Mostly animal studies |
| TB-500 | A 7-amino-acid piece of a protein called thymosin beta-4 | Wound healing, cell movement | Cell and animal studies |
Sources for this table: [2], [3], [4].
A simple way to picture the blend: GHK-Cu is the “skin” ingredient, while BPC-157 and TB-500 are the “repair” ingredients that researchers usually study for muscles, tendons and wounds.
With three peptides in one vial, quality matters for any lab study. Researchers often source blends like GLOW from trusted platforms such as PeptidePro, and they usually look for batch purity testing and a certificate of analysis (COA), a lab report that confirms what is in each batch. These compounds are supplied for research use only, not for human consumption.
Why Is GLOW Linked to Skin?
The skin link comes from GHK-Cu. It is a small peptide that holds a copper ion, and the body makes it naturally. Its level in the blood drops with age, from about 200 ng/mL at age 20 to about 80 ng/mL at age 60 [4].
GHK-Cu has been tested in people, but only in products put on the skin. A 2018 review describes several of these small cream studies [4]:
| Study (as described in the review) | Who took part | Length | What researchers reported |
|---|---|---|---|
| Facial cream | 71 women, no comparison group | 12 weeks | Thicker, denser skin and fewer fine lines |
| Eye cream | 41 women, compared with placebo and a vitamin K cream | 12 weeks | Fewer lines and wrinkles |
| Thigh skin cream | Compared with vitamin C cream and retinoic acid | 12 weeks | More collagen in 70% of users vs 50% (vitamin C) and 40% (retinoic acid) |
Collagen is the protein that keeps skin firm, a bit like the springs inside a mattress. Keep the limits in mind: these were small studies of creams, so they say nothing about GLOW as a blend or about GHK-Cu given any other way. GHK-Cu is one of several peptides for skin found in creams, and studies like these are the main reason the GHK-Cu copper peptide is tied to skin research.
What Does GLOW Peptide Do in Research?
People searching for GLOW peptide benefits often want to know what the blend does. Because the blend itself has not been studied, the answer comes from each ingredient on its own:
| Ingredient | Key source | Study type | What was found |
|---|---|---|---|
| GHK-Cu | Pickart and Margolina, 2018 [4] | Review of cell, animal and human cream studies | Roles in skin repair, collagen and wound healing |
| BPC-157 | Vasireddi et al., 2025 [2] | Systematic review of 36 studies | 35 were animal or lab studies and 1 was a small human look-back study. Human safety is unknown. |
| TB-500 | Product research summary [3] | Cell and mouse studies | Applied to mouse skin, it was linked to faster wound healing |
A systematic review gathers and grades all earlier studies on a topic. A look-back study reviews past records rather than testing something new, so it counts as weaker evidence.
Do GLOW Peptides Actually Work?
There is no clear answer yet, because the blend has never been tested. Here is what the evidence can and cannot say:
- What it can say: GHK-Cu creams were linked to skin changes in small human studies, and BPC-157 and TB-500 showed tissue repair effects in animals.
- What it cannot say: whether the three work better together, whether results from creams or animals carry over to the blend, or whether the mix is safe.
Think of it like three songs that each sound good alone. Nobody can say how they sound played at the same time until someone actually plays them together.
GLOW vs KLOW vs NAD+: What Is the Difference?
These three names often come up together, but they are not the same kind of thing. NAD+ is not a peptide at all. It is a coenzyme, a helper molecule that cells use in energy reactions, and its levels fall with age [5]. That role in energy is the key point about what NAD is, and it is why NAD+ belongs to aging research rather than to skin peptides.
| GLOW | KLOW | NAD+ | |
|---|---|---|---|
| What it is | Blend of 3 peptides | Blend of 4 peptides | A single coenzyme, not a peptide |
| Ingredients | GHK-Cu, BPC-157, TB-500 | GHK-Cu, BPC-157, TB-500, KPV | NAD+ only |
| Main research area | Skin and tissue repair | Tissue repair and inflammation | Energy use in cells and aging |
So the KLOW vs GLOW peptide question comes down to one ingredient: KLOW adds KPV [1], a small peptide that has been studied for gut inflammation in mice [7].
GLOW Peptide Side Effects and Downsides
There is no side effect data for the GLOW blend, because it has not been studied as a blend. What is known comes from each ingredient:
| Ingredient | What is known about safety |
|---|---|
| GHK-Cu | Human studies used creams on the skin. Other routes have not been tested in the same way [4] |
| BPC-157 | A 2025 review concluded that its safety in humans is unknown [2] |
| TB-500 | Research suppliers label it “not for human or veterinary use” [3] |
The main downsides of GLOW peptides are about what is missing:
- No blend data. Nobody has published how the three behave together.
- Little human data. Most findings come from cells, animals or skin creams.
- Unknown long-term effects. No long-term studies exist for the blend.
Missing data is not proof of harm, but it is also not proof of safety.
Is GLOW Banned in Sport?
Yes, in practice. Two of its three ingredients appear on the anti-doping list that follows the World Anti-Doping Agency (WADA) rules for 2026 [6]:
- BPC-157 is named under S0, the class for non-approved substances.
- TB-500 is named under S2, as a derivative of thymosin beta-4.
Both classes are prohibited at all times, in and out of competition. GHK-Cu is not named on the list.
Frequently Asked Questions
Do GLOW peptides actually work?
There is no direct evidence either way, because the GLOW blend has not been tested in published studies. GHK-Cu creams were linked to skin changes in small human studies, and BPC-157 and TB-500 showed repair effects in animals. Whether those results carry over to the blend is still unknown.
What are the downsides of GLOW peptides?
The biggest downside is missing data. The blend has never been studied, human research on its ingredients is limited, and a 2025 review found that the safety of BPC-157 in humans is unknown. Two ingredients, BPC-157 and TB-500, are also banned in sport at all times.
What is the difference between NAD+ and GLOW?
GLOW is a blend of three peptides: GHK-Cu, BPC-157 and TB-500. NAD+ is not a peptide. It is a coenzyme, a helper molecule cells use in energy reactions, and its levels fall with age. GLOW is mainly linked to skin and tissue repair research, while NAD+ is linked to energy and aging research.
What is in GLOW peptide?
GLOW contains three research peptides. GHK-Cu is a small copper-binding peptide studied for skin. BPC-157 is a 15-amino-acid peptide studied mostly in animals for tissue repair. TB-500 is a short piece of the protein thymosin beta-4, studied in cells and animals for wound healing.
Is GLOW the same as KLOW?
No, but they are close. KLOW contains everything in GLOW (GHK-Cu, BPC-157 and TB-500) plus a fourth peptide, KPV. KPV is a small fragment of the hormone alpha-MSH that has been studied for gut inflammation in mice. Neither blend has been tested as a whole in published research.
Disclaimer
This article is provided for educational and informational purposes only and does not constitute medical advice. The compounds discussed are research compounds and are not intended for human consumption. Anyone considering the use of any peptide should first consult a qualified, licensed healthcare professional, who can assess their individual circumstances and advise on what is most appropriate for them.
References
- Superpower. GLOW peptide guide, which lists GLOW’s ingredients and describes KLOW as GLOW plus KPV.
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS Journal. 2025;21(4):485-495.
- Cayman Chemical. TB-500 (acetate) product information.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119-141.
- Voluntary Anti-Doping Association. VADA Prohibited List 2026, which tracks the WADA 2026 Prohibited List.
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-331.